The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia
Condition(s):Treatment-resistant Schizophrenia; Treatment-responsive Schizophrenia; Healthy ControlsLast Updated:March 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Treatment-resistant Schizophrenia; Treatment-responsive Schizophrenia; Healthy ControlsLast Updated:March 5, 2024Recruiting
Condition(s):Treatment Resistant DepressionLast Updated:February 6, 2024Recruiting
Condition(s):Treatment Resistant DepressionLast Updated:February 24, 2023Recruiting
Condition(s):Treatment Resistant DepressionLast Updated:September 27, 2019Unknown status
Condition(s):Treatment Resistant DepressionLast Updated:May 1, 2023Active, not recruiting
Condition(s):Treatment-resistant SchizophreniaLast Updated:January 21, 2020Terminated
Condition(s):Treatment Resistant DepressionLast Updated:November 7, 2023Not yet recruiting
Condition(s):Treatment Resistant DepressionLast Updated:July 11, 2013Unknown status
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:September 21, 2016Unknown status
Condition(s):HypertensionLast Updated:February 28, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.